Uncommon cancers of the small intestine, appendix and colon: An analysis of SEER 1973-2004, and current diagnosis and therapy

International Journal of Oncology

Volumn 33, Issue 6, 2008, Pages 1121-1131

  Gustafsson, Bjorn I ^a,b,c   Siddique, Luna ^a   Chan, Anthony ^a   Dong, Manku ^a,d   Drozdov, Ignat ^a   Kidd, Mark ^a   Modlin, Irvin M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d 306 HOSPITAL OF PLA   (China)

Author keywords

Adenocarcinoma; Carcinoid; Epidemiology; Lymphoma; Neuroendocrine; Sarcoma; SEER; Tumor

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GAMMA INTERFERON; IMATINIB; MITOMYCIN C; PREDNISOLONE; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOSTATIN RECEPTOR; STREPTOZOCIN; SUNITINIB; VINCRISTINE SULFATE;

ADENOCARCINOMA; APPENDIX CANCER; BLEEDING; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAPSULE ENDOSCOPY; CLINICAL TRIAL; COLON CANCER; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; DOUBLE BALLOON ENTEROSCOPY; DRUG TARGETING; DRUG TOLERABILITY; EDEMA; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHOMA; ISOTOPE LABELING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOMA; SMALL INTESTINE CANCER; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR SCINTISCANNING; UNSPECIFIED SIDE EFFECT; APPENDIX TUMOR; CANCER REGISTRY; COLON TUMOR; INTESTINE TUMOR; LYMPHOMA; PATHOLOGY; SMALL INTESTINE; SURVIVAL; TIME; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; APPENDICEAL NEOPLASMS; COLONIC NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPHOMA; NEUROENDOCRINE TUMORS; SARCOMA; SEER PROGRAM; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 59049087829     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000101     Document Type: Review

References (68)

1. Liszka L, Zielinska-Pajak E, Pajak J, Golka D and Huszno J: Coexistence of gastrointestinal stromal tumors with other neoplasms. J Gastroenterol 42: 641-649, 2007.
2. Roberts MC, Millikan RC, Galanko JA, Martin C and Sandler RS: Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 98: 857-864, 2003.
3. Ciresi DL and Scholten DJ: The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 61: 698-702, 1995.
4. Grunkemeier GL, Anderson RP and Starr A: Actuarial and actual analysis of surgical results: empirical validation. Ann Thorac Surg 71: 1885-1887, 2001.
5. Oberndorfer S: Karzinoide tumoren des dunndarms. Frankf Z Pathol 1: 426-423, 1907.
6. Gustafsson BI, Kidd M and Modlin IM: Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol 20: 1-12, 2008.
7. Modlin IM, Kidd M, Latich I, Zikusoka MN and Shapiro MD: Current status of gastrointestinal carcinoids. Gastroenterology 128: 1717-1751, 2005.
8. The US National Cancer Institute, Surveillance Epidemiology and End Results (SEER) data base, 1973-2004, http://seer.cancer.gov/.2007.
9. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU and Kloppel G: Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68: 1329-1334, 1991.
10. House MG, Yeo CJ and Schulick RD: Periampullary pancreatic somatostatinoma. Ann Surg Oncol 9: 869-874, 2002.
11. Hoffmann KM, Furukawa M and Jensen RT: Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 19: 675-697, 2005.
12. Zar N, Garmo H, Holmberg L, Rastad J and Hellman P: Longterm survival of patients with small intestinal carcinoid tumors. World J Surg 28: 1163-1168, 2004.
13. Dumper J, Mackenzie S, Mitchell P, Sutherland F, Quan ML and Mew D: Complications of Meckel's diverticula in adults. Can J Surg 49: 353-357, 2006.
14. Anderson DJ: Carcinoid tumor in Meckel's diverticulum: laparoscopic treatment and review of the literature. J Am Osteopath Assoc 100: 432-434, 2000.
15. Pahlavan PS and Kanthan R: Goblet cell carcinoid of the appendix. World J Surg Oncol 3: 36, 2005.
16. Howe JR, Karnell LH, Menck HR and Scott-Conner C: The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 86: 2693-2706, 1999.
17. Verma D and Stroehlein JR: Adenocarcinoma of the small bowel: a 60-year perspective derived from M.D. Anderson Cancer Center Tumor Registry. Am J Gastroenterol 101: 1647-1654, 2006.
18. Dabaja BS, Suki D, Pro B, Bonnen M and Ajani J: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101: 518-526, 2004.
19. Solem CA, Harmsen WS, Zinsmeister AR and Loftus EV Jr: Small intestinal adenocarcinoma in Crohn's disease: a case-control study. Inflamm Bowel Dis 10: 32-35, 2004.
20. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B and Neugut AI: Risk of malignancy in patients with celiac disease. Am J Med 115: 191-195, 2003.
21. Xie J and Itzkowitz SH: Cancer in inflammatory bowel disease. World J Gastroenterol 14: 378-389, 2008.
22. Burke CA, Santisi J, Church J and Levinthal G: The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 100: 1498-1502, 2005.
23. Ito H, Osteen RT, Bleday R, Zinner MJ, Ashley SW and Whang EE: Appendiceal adenocarcinoma: long-term outcomes after surgical therapy. Dis Colon Rectum 47: 474-480, 2004.
24. Damaj G, Verkarre V, Delmer A, et al: Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol 14: 623-629, 2003.
25. Grogg KL, Miller RF and Dogan A: HIV infection and lymphoma. J Clin Pathol 60: 1365-1372, 2007.
26. Yin L, Chen CQ, Peng CH, et al: Primary small-bowel non-Hodgkin's lymphoma: a study of clinical features, pathology, management and prognosis. J Int Med Res 35: 406-415, 2007.
27. Isaacson PG and Du MQ: Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 205: 255-274, 2005.
28. Romaguera J and Hagemeister FB: Lymphoma of the colon. Curr Opin Gastroenterol 21: 80-84, 2005.
29. Wong MT and Eu KW: Primary colorectal lymphomas. Colorectal Dis 8: 586-591, 2006.
30. Zighelboim J and Larson MV: Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy. J Clin Gastroenterol 18: 291-297, 1994.
31. Romaguera JE, Medeiros LJ, Hagemeister FB, et al: Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 97: 586-591, 2003.
32. Bumming P, Ahlman H, Andersson J, Meis-Kindblom JM, Kindblom LG and Nilsson B: Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours. Br J Surg 93: 836-843, 2006.
33. Nilsson B, Bumming P, Meis-Kindblom JM, et al: Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer 103: 821-829, 2005.
34. Perez EA, Gutierrez JC, Jin X, et al: Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination. J Gastrointest Surg 11: 114-125, 2007.
35. Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G and Chan AK: Gastrointestinal carcinoids: the evolution of diagnostic strategies. J Clin Gastroenterol 40: 572-582, 2006.
36. Yamaguchi T, Manabe N, Tanaka S, et al: Multiple carcinoid tumors of the ileum preoperatively diagnosed by enteroscopy with the double-balloon technique. Gastrointest Endosc 62: 315-318, 2005.
37. Cobrin GM, Pittman RH and Lewis BS: Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer 107: 22-27, 2006.
38. Nickl NJ: Gastrointestinal stromal tumors: new progress, new questions. Curr Opin Gastroenterol 20: 482-487, 2004.
39. Ramachandran I, Sinha R, Rajesh A, Verma R and Maglinte DD: Multidetector row CT of small bowel tumours. Clin Radiol 62: 607-614, 2007.
40. Pilleul F, Penigaud M, Milot L, Saurin JC, Chayvialle JA and Valette PJ: Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241: 796-801, 2006.
41. Rodrigues M, Traub-Weidinger T, Li S, Ibi B and Virgolini I: Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 33: 532-540, 2006.
42. Koopmans KP, De Vries EG, Kema IP, et al: Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 7: 728-734, 2006.
43. Seemann MD: Detection of metastases from gastrointestinal neuroendocrine tumors: prospective comparison of 18F-TOCA PET, triple-phase CT, and PET/ CT. Technol Cancer Res Treat 6: 213-220, 2007.
44. Elstrom R, Guan L, Baker G, et al: Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101: 3875-3876, 2003.
45. Jager PL, Gietema JA and van der Graaf WT: Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun 25: 433-438, 2004.
46. Espinosa I, Lee CH, Kim MK, et al: A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 32: 210-218, 2008.
47. Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T and Moriyasu F: Endoscopic resection of carcinoid of the minor duodenal papilla. World J Gastroenterol 13: 3763-3764, 2007.
48. Merg A, Wirtzfeld D, Wang J, Cheney R, Dunn KB and Rajput A: Viability of endoscopic and excisional treatment of early rectal carcinoids. J Gastrointest Surg 11: 893-897, 2007.
49. Kerstrom G, Hellman P and Hessman O: Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 19: 717-728, 2005.
50. Stinner B and Rothmund M: Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol 19: 729-738, 2005.
51. Modlin IM, Latich I, Kidd M, Zikusoka M and Eick G: Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol 4: 526-547, 2006.
52. Eriksson B, Kloppel G, Krenning E, et al: Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87: 8-19, 2008.
53. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, et al: Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 46 (Suppl. 1): S62-S66, 2005.
54. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM and Que FG: Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197: 29-37, 2003.
55. Mazzaferro V, Pulvirenti A and Coppa J: Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol 47: 460-466, 2007.
56. Wu TJ, Yeh CN, Chao TC, Jan YY and Chen MF: Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg 30: 391-399, 2006.
57. O'Donnell ME, Badger SA, Beattie GC, Carson J and Garstin WI: Malignant neoplasms of the appendix. Int J Colorectal Dis 22: 1239-1248, 2007.
58. Singhal N and Singhal D: Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev 3: CD005202, 2007.
59. Talamonti MS, Goetz LH, Rao S and Joehl RJ: Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 137: 564-570, 2002.
60. Nakamura S, Matsumoto T, Iida M, Yao T and Tsuneyoshi M: Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97: 2462-2473, 2003.
61. Lee J, Kim WS, Kim K, et al: Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res 31: 359-364, 2007.
62. Brandt L, Kimby E, Nygren P and Glimelius B: A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma. Acta Oncol 40: 213-223, 2001.
63. Daum S, Ullrich R, Heise W, et al: Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal Non-Hodgkin's Lymphoma. J Clin Oncol 21: 2740-2746, 2003.
64. Al-Toma A, Verbeek WH, Visser OJ, et al: Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis 39: 634-641, 2007.
65. Blay JY, Bonvalot S, Casali P, et al: Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16: 566-578, 2005.
66. Joensuu H: Second line therapies for the treatment of gastrointestinal stromal tumor. Curr Opin Oncol 19: 353-358, 2007.
67. Delbaldo C, Chatelut E, Re M, et al: Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors. Clin Cancer Res 12: 6073-6078, 2006.
68. Demetri GD, van Oosterom AT, Garrett CR, et al: Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368: 1329-1338, 2006.